Patents by Inventor Regis Perichon

Regis Perichon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME
    Publication number: 20200103417
    Abstract: Biomarkers of kidney function and methods for using said biomarkers for assessing kidney function, monitoring kidney function, diagnosing acute kidney injury, and diagnosing chronic kidney disease are provided. Also provided are suites of small molecule entities as biomarkers for chronic kidney disease.
    Type: Application
    Filed: December 2, 2019
    Publication date: April 2, 2020
    Inventors: Regis Perichon, Jeffery Edmond Cobb, Meredith V. Brown, Adam Kennedy
  • Biomarkers related to kidney function and methods using the same
    Patent number: 10539575
    Abstract: Biomarkers of kidney function and methods for using said biomarkers for assessing kidney function, monitoring kidney function, diagnosing acute kidney injury, and diagnosing chronic kidney disease are provided. Also provided are suites of small molecule entities as biomarkers for chronic kidney disease.
    Type: Grant
    Filed: May 13, 2014
    Date of Patent: January 21, 2020
    Assignee: METABOLON, INC.
    Inventors: Regis Perichon, Jeffery Edmond Cobb, Meredith V. Brown, Adam Kennedy
  • Biomarkers for Fatty Liver Disease and Methods Using the Same
    Publication number: 20170370954
    Abstract: Biomarkers of NASH, NAFLD, and fibrosis and methods for diagnosis (or aiding in the diagnosis) of NAFLD, NASH and/or fibrosis are described herein. Additionally, methods of distinguishing between NAFLD and NASH, methods of classifying the stage of fibrosis, methods of determining the severity of liver disease, methods of determining the severity of liver disease or fibrosis, and methods of monitoring progression/regression of NASH, NAFLD, and/or fibrosis are described herein.
    Type: Application
    Filed: November 18, 2015
    Publication date: December 28, 2017
    Inventors: Regis Perichon, Lauren Nicole Bell, Jacob Wulff, Uyen Thao Nguyen, Steven M. Watkins
  • BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME
    Publication number: 20160116486
    Abstract: Biomarkers of kidney function and methods for using said biomarkers for assessing kidney function, monitoring kidney function, diagnosing acute kidney injury, and diagnosing chronic kidney disease are provided. Also provided are suites of small molecule entities as biomarkers for chronic kidney disease.
    Type: Application
    Filed: May 13, 2014
    Publication date: April 28, 2016
    Inventors: Regis PERICHON, Jeffrey Edmond COBB, Meredith V. BROWN, Adam KENNEDY
  • Biomarkers for Bladder Cancer and Methods Using the Same
    Publication number: 20150065366
    Abstract: Methods for identifying and evaluating biochemical entities useful as biomarkers for bladder cancer, target identification/validation, and monitoring of drug efficacy are provided. Also provided are suites of small molecule entities as biomarkers for bladder cancer.
    Type: Application
    Filed: November 8, 2012
    Publication date: March 5, 2015
    Inventors: Jonathan E. McDunn, Regis Perichon, Bruce Neri, Bryan Wittmann
  • SERUM BIOMARKERS FOR CHAGAS DISEASE
    Publication number: 20120172356
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Chagas disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as infected with Chagas disease or non-infected. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: October 25, 2011
    Publication date: July 5, 2012
    Applicant: MCGILL UNIVERSITY
    Inventors: Momar NDAO, Brian WARD, Hongshan LI, Vladimir PODUST, Rebecca CAFFREY, Terrance William SPITHILL, Regis PERICHON
  • Serum biomarkers for Chagas disease
    Patent number: 8043825
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Chagas disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as infected with Chagas disease or non-infected. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Grant
    Filed: December 6, 2004
    Date of Patent: October 25, 2011
    Assignee: McGill University
    Inventors: Momar Ndao, Brian Ward, Rebecca Caffrey, Terence William Spithill, Hongshan Li, Vladimir Podust, Regis Perichon
  • Serum biomarkers for Chagas disease
    Publication number: 20050260691
    Abstract: The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Chagas disease status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as infected with Chagas disease or non-infected. The biomarkers can be detected by SELDI mass spectrometry.
    Type: Application
    Filed: December 6, 2004
    Publication date: November 24, 2005
    Applicant: Ciphergen Biosystems, Inc.
    Inventors: Momar Ndao, Brian Ward, Rebecca Caffrey, Terence Spithill, Hongshan Li, Vladimir Podust, Regis Perichon